Central nervous system-active drug abused and overdose in children: a worldwide exploratory study using the WHO

Carla Carnovale1, Faizan Mahzar2, Sara Scibelli2

  • 1Unit of Clinical Pharmacology Department of Biomedical and Clinical Sciences L. Sacco, "Luigi Sacco" University Hospital, Università di Milano, 20157, Milan, Italy. carla.carnovale@unimi.it.

Insights

Pediatric drug abuse and overdose reports, particularly involving central nervous system (CNS)-active medications, are rising globally. Opioid and paracetamol use in fatal overdoses highlights the urgent need for increased clinical awareness and risk-minimization strategies.

Area of Science:

  • Pharmacovigilance
  • Epidemiology
  • Paediatric Drug Safety

Background:

  • Recent epidemiological studies indicate a growing concern regarding the abuse and overdose of central nervous system (CNS)-active drugs in pediatric populations.
  • Existing research has not comprehensively addressed the global scope of this issue in children.
  • Increased prescriptions for CNS-active drugs in the past two decades have heightened public health concerns about potential misuse and adverse events.

Purpose of the Study:

  • To conduct a worldwide analysis of drug abuse and overdose reports involving pediatric patients over the last decade.
  • To identify trends, common suspect drugs, and outcomes associated with CNS-active drug abuse in children.
  • To provide data that can inform global risk-minimization strategies and healthcare recommendations.

Main Methods:

  • Utilized VigiBase, the largest global pharmacovigilance database, to collect adverse drug reaction reports.
  • Focused on reports involving suspect drugs classified under the Anatomical Therapeutic Chemical code "Nervous System".
  • Employed Standardised Medical Dictionary for Drug Regulatory Affairs Queries for Drug abuse to filter relevant cases, analyzing 8,682 matched reports.

Main Results:

  • A significant increase in reporting activity for pediatric drug abuse and overdose was observed, starting around 2014.
  • Intentional overdoses were reported more frequently than accidental ones, with variations across different pediatric age groups.
  • Out of 997 reports with a fatal outcome, adolescents were disproportionately represented (538 reports).
  • Paracetamol and opioid analgesics were the most frequently implicated drugs in fatal cases, often leading to hypoxic-ischaemic encephalopathy and cardio-respiratory arrest.

Conclusions:

  • The number of reported cases of drug abuse and overdose involving CNS-active medications, including opioid and paracetamol-containing products, is increasing in pediatric populations.
  • A substantial proportion of these reported adverse drug reactions are serious, with a notable number resulting in fatalities.
  • Data analysis reveals that opioid and paracetamol are key drugs associated with fatal outcomes in pediatric overdose cases.
  • There is a critical need for enhanced clinical awareness regarding pediatric drug abuse and overdose, alongside the implementation of targeted risk-minimization strategies and updated healthcare guidelines worldwide.

Related Concept Videos

Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.3K
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.7K
What is a Nervous System?01:25

What is a Nervous System?

Overview
104.8K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
295
The Parasympathetic Nervous System01:14

The Parasympathetic Nervous System

Overview
115.5K
The Sympathetic Nervous System01:25

The Sympathetic Nervous System

Overview
103.6K